COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 928: Articles 9271-9280  | Next

A mixed methods analysis of participation in social contact surveys
Nixon, E. J., Silvonen, T., Barreaux, A., Kwiatkowska, R., Trickey, A., Thomas, A. C., Ali, B., Treneman-evans, G., Christensen, H., Brooks Pollock, E., Denford, S.
10.1101/2022.01.28.22270006 — Posted: 2022-01-29
Comparative effectiveness of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign
Lytras, T., Kontopidou, F., Lambrou, A., Tsiodras, S.
10.1101/2022.01.28.22270009 — Posted: 2022-01-29 Discussion: Onsite
Neutralizing Activities against the Omicron Variant after a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination
Assawakosri, S., Kanokudom, S., Suntronwong, N., Auphimai, C., Nilyanimit, P., Vichaiwattana, P., Thongmee, T., Duangchinda, T., Chantima, W., Pakchotanon, P., Srimuan, D., Thatsanatorn, T., Klinfueng, S., Yorsaeng, R., Sudhinaraset, N., Wanlapakorn, N., Mongkolsapaya, J., Honsawek, S., Poovorawan, Y.
10.1101/2022.01.28.22269986 — Posted: 2022-01-29
A Micronized Electrostatic Precipitator Respirator Effectively Removes Ambient SARS-CoV-2 Bioaerosols
Redmann, R. K., Beddingfield, B. J., Spencer, S., Chirichella, N. R., Henley, J., Hager, W., ROY, C. J.
10.1101/2022.01.27.22269961 — Posted: 2022-01-28
Persistently reduced humoral and cellular immune response following third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients
Bajwa, H. M., Novak, F., Nilsson, A. C., Nielsen, C., Holm, D. K., Oestergaard, K., Witt, A. H., Byg, K.-E., Johansen, I. S., Mittl, K., Rowles, W., Zamvil, S., Bove, R., Sabatino, J. J., Sejbaek, T.
10.1101/2022.01.27.22269944 — Posted: 2022-01-28
Who was wearing a mask in 2021? Update on gender-, age-, and location-related differences during the COVID-19 pandemic
Haischer, M. H., Beilfuss, R. N., Hart, M. R., Opielinski, L., Schmit, E., Wrucke, D., Zhao, H., Uhrich, T. D., Hunter, S. K.
10.1101/2022.01.18.22269479 — Posted: 2022-01-28
Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions
Parker, E., Anderson, C., Zeller, M., Tibi, A., Havens, J. L., Laroche, G., Benlarbi, M., Ariana, A., Robles-Sikisaka, R., Latif, A., Watts, A., Awidi, A., Jaradat, S. A., Gangavarapu, K., Kurzban, E., Matteson, N. L., Han, A. X., Hughes, L. D., McGraw, M., Spencer, E., Nicholson, L., Khan, K., Suchard, M. A., Wertheim, J. O., Wohl, S., Cote, M., Abdelnour, A., Andersen, K. G., Abu-Dayyeh, I.
10.1101/2022.01.27.22269922 — Posted: 2022-01-28
Evaluation of the CD4+ T cell response to SARS-CoV-2 infection and cross reactivity to beta variant in children of all ages
Paul, K., Sibbertsen, F., Weiskopf, D., Luetgehetmann, M., Barroso, M., Danecka, M. K., Glau, L., Hecher, L., Hermann, K., Kohl, A., Oh, J., Schulze zur Wiesch, J., Sette, A., Tolosa, E., Vettorazzi, E., Woidy, M., Zapf, A., Zazara, D. E., Mir, T. S., Muntau, A. C., Gersting, S. W., Dunay, G. A.
10.1101/2022.01.27.22269976 — Posted: 2022-01-28
Screening for SARS-CoV-2 in close contacts of individuals with confirmed infection: performance and operational considerations
Zobrist, S., Oliveira-Silva, M., Vieira, A. M., Bansil, P., Gerth-Guyette, E., Leader, B. T., Golden, A., Slater, H., Cruz, C. D. d. L., Garbin, E., Sagalovsky, M., Pal, S., Gupta, V., Wolansky, L., Dall Acqua, D. S. V., Naveca, F. G., Nascimento, V. A. d., Villalobos Salcedo, J. M., Drain, P. K., Costa, A. D. T., Domingo, G. J., Pereira, D.
10.1101/2022.01.27.22269904 — Posted: 2022-01-28
Analysis of Fatality Impact and Seroprevalence Surveys in a Community Sustaining a SARS-CoV-2 Superspreading Event
Richter, E., Liebl, D., Schulte, B., Lehmann, N., Fuhrmann, C., Joeckel, K.-H., Ioannidis, J., Streeck, H.
10.1101/2022.01.26.22269805 — Posted: 2022-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).